Cerebral Venous Oxygen Saturation in Hypoperfusion Regions May Become a New Imaging Indicator to Predict the Clinical Outcome of Stroke.
Fengqiu CaoMingming WangShengyu FanShanhua HanYingwei GuoAsim ZamanJia GuoYu LuoYan KangPublished in: Life (Basel, Switzerland) (2022)
To automatically and quantitatively evaluate the venous oxygen saturation (SvO2) in cerebral ischemic tissues and explore its value in predicting prognosis. A retrospective study was conducted on 48 AIS patients hospitalized in our hospital from 2015-2018. Based on quantitative susceptibility mapping and perfusion-weighted imaging, this paper measured the cerebral SvO2 in hypoperfusion tissues and its change after intraarterial rt-PA treatment. The cerebral SvO2 in different hypoperfusion regions between the favorable and unfavorable clinical outcome groups was analyzed using an independent t -test. Relationships between cerebral SvO2 and clinical scores were determined using the Pearson correlation coefficient. The receiver operating characteristic process was conducted to evaluate the accuracy of cerebral SvO2 in predicting unfavorable clinical outcomes. Cerebral SvO2 in hypoperfusion (Tmax > 4 and 6 s) was significantly different between the two groups at follow-up ( p < 0.05). Cerebral SvO2 and its changes before and after treatment were negatively correlated with clinical scores. The positive predictive value, negative predictive value, accuracy, and area under the curve of the cerebral SvO2 were higher than those predicted by the ischemic core. Therefore, the cerebral SvO2 of hypoperfusion regions was a stronger imaging predictor of unfavorable clinical outcomes after stroke.
Keyphrases
- subarachnoid hemorrhage
- cerebral ischemia
- high resolution
- cognitive impairment
- brain injury
- gene expression
- emergency department
- cerebral blood flow
- end stage renal disease
- magnetic resonance
- oxidative stress
- atrial fibrillation
- computed tomography
- peritoneal dialysis
- newly diagnosed
- photodynamic therapy
- blood brain barrier
- mass spectrometry
- high density
- acute care